Research advances in pancreatic exocrine insufficiency secondary to pancreatic cancer
DOI:10.3969/j.issn.1001-5256.2021.04.057
- VernacularTitle:继发于胰腺癌的胰腺外分泌功能不全的研究进展
- Author:
Chenguang SHI
1
;
Xiaohuan LIU
;
Yaxing XIE
;
Yanbo MA
Author Information
1. The First Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China
- Publication Type:Research Article
- Keywords:
Pancreatic Neoplasms;
Exocrine Pancreatic Insufficiency;
Pancreatic Enzyme Replacement Therapy
- From:
Journal of Clinical Hepatology
2021;37(4):982-984
- CountryChina
- Language:Chinese
-
Abstract:
At present, there is still a lack of comprehensive diagnosis and treatment criteria for pancreatic exocrine insufficiency around the world. Pancreatic surgeons often ignore or misjudge pancreatic exocrine insufficiency secondary to pancreatic cancer, and as a result, pancreatic exocrine insufficiency is not adequately treated, which greatly affects the quality of life of patients with pancreatic cancer. This article summarizes the latest research advances in the pathogenesis, typical symptoms, and diagnostic methods of pancreatic exocrine insufficiency, as well as pancreatic enzyme replacement therapy in different stages of pancreatic cancer. It is pointed out that pancreatic enzyme replacement therapy can significantly improve the quality of life of patients with different stages of pancreatic cancer.
